Physician

Nicholas Roy, D.O.

According to 2025 Medicare claims, Nicholas Roy, D.O. (NPI: 1619288073) practices pulmonary disease in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is INSPIRA HEALTH NETWORK MEDICAL GROUP, P.C. (NPI: 1922177856; TIN: 205745047) and primary practice location at 08360-9998. Roy is affiliated with the St. Luke's Medicare ACO (ACO ID: A3560) and Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Roy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 362 traditional Medicare patients, billed 1,381 HCPCS/CPT codes, and received $115,456 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 815 prescription claims across 253 beneficiaries totaling $363,092 in drug costs, led by Dupixent Pen (Dupilumab). DME data shows 1,431 claims. Open Payments data shows 86 records totaling $1,390. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $166,854 to $115,456. In contrast, Part D prescription costs have moved sharply higher in recent years, from $6,770 to $363,092. For DME billing, reported payments moved sharply higher in recent years, from $8,529 to $59,207.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$133K$265K2016 Medicare payment: $166,854 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $265,371 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $252,982 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $232,889 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $239,009 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $226,731 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $216,523 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $201,189 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $115,456 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20168291,815$166,854
20171,2713,060$265,371
20181,0953,115$252,982
20191,0192,805$232,889
20208772,406$239,009
20218762,331$226,731
20229092,255$216,523
20238262,053$201,189
20243621,381$115,456

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$513K$1.0M2015 Drug cost: $6,770 (USD; Tot_Drug_Cst)2016 Drug cost: $3,767 (USD; Tot_Drug_Cst)2017 Drug cost: $1,630 (USD; Tot_Drug_Cst)2018 Drug cost: $30,015 (USD; Tot_Drug_Cst)2019 Drug cost: $131,874 (USD; Tot_Drug_Cst)2020 Drug cost: $188,879 (USD; Tot_Drug_Cst)2021 Drug cost: $379,086 (USD; Tot_Drug_Cst)2022 Drug cost: $824,321 (USD; Tot_Drug_Cst)2023 Drug cost: $1,025,463 (USD; Tot_Drug_Cst)2024 Drug cost: $363,092 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153679$6,770
20162035$3,767
20171529$1,630
201856150$30,015
2019108425$131,874
2020113599$188,879
20212191,096$379,086
20223812,154$824,321
20234022,581$1,025,463
2024253815$363,092

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$77K$153K2018 Medicare payment: $1,499 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $14,372 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $27,313 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $53,594 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $124,388 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $153,384 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $72,349 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R34$1,499
2019N/R129$14,372
202039402$27,313
2021183727$53,594
20226101,779$124,388
20237832,370$153,384
20245601,431$72,349

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes86100$152
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more8384$145
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more126200$114
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes124311$70
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's118184$14

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab381,064$152,564
Trelegy ElliptaFluticasone/Umeclidin/Vilanter1294,770$98,221
Breo ElliptaFluticasone/Vilanterol612,070$26,672
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr18960$14,486
Breztri AerosphereBudesonide/Glycopyr/Formoterol11570$11,304

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J7677Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgramNN/R16$12,095
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateY20133$8,393
A7031Face mask interface, replacement for full face mask, eachN4092$7,808
A7030Full face mask used with positive airway pressure device, eachN4396$7,666
A4604Tubing with integrated heating element for use with positive airway pressure deviceN71156$5,872

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.86$1,390AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Nicholas Roy, D.O.?

Tedicare shows public-source Medicare data for Nicholas Roy, D.O. (NPI 1619288073), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nicholas Roy, D.O. have ACO affiliation data?

Nicholas Roy, D.O. is shown with ACO affiliation data for St. Luke's Medicare ACO (MSSP, ACO ID A3560) and Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Nicholas Roy, D.O.?

Nicholas Roy, D.O. is linked to INSPIRA HEALTH NETWORK MEDICAL GROUP, P.C. (billing NPI 1922177856) in the available physician profile data.

Does Nicholas Roy, D.O. have Open Payments data?

Nicholas Roy, D.O. has 86 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.